Basic & Clinical Medicine ›› 2012, Vol. 32 ›› Issue (3): 305-308.
Previous Articles Next Articles
TONG An-li
Received:
Revised:
Online:
Published:
Contact:
Abstract: Objectives: To study the effects of EGF and angiotensinII on ERK pathways in adrenocortical carcinoma H295R Cells. Methods: Treated with EGF and angiotensin II with different concentrations, phosphorylation of ERK1/2 was detected by Western blot. The effect of Angiotensin II on phospho-ERK1/2 was also observed when pretreated with the specific inhibitor of the EGF receptor tyrosine kinase, AG1478. Treated with EGF and angiotensin II alone or both, phosphorylation of ERK1/2,p90RSK and Bad was detected. Results: Both EGF and angiotensin II increased phospho-ERK1/2 in a dose-dependent manner, and they also promoted phospho-p90RSK. EGF and angiotensin II showed an additive effect on phosphorylation of ERK1/2 and p90RSK. Treated by Angiotensin II and EGF alone or both, phospho-ERK1/2 were 6.3±1.4、2.2±0.6 and 10.1±1.1, respectively, relatived to the control. Angiotensin II, but not EGF, stimulated phospho-Bad. The effects of angiotensin II on phospho-ERK1/2 was not blocked by AG1478. Conclusion: Both EGF and Angiotensin II promotes ERK pathway, and they show an additive effect in H295R cells.
Key words: EGF, H295R cell, pathway, angiotensin II
CLC Number:
R586
TONG An-li. Activation of ERK Pathway by EGF and Angiotensin II in Adrenocortical Carcinoma H295R Cells[J]. Basic & Clinical Medicine, 2012, 32(3): 305-308.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/
http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2012/V32/I3/305